Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.

Santschi V, Chiolero A, Colosimo AL, Platt RW, Taffé P, Burnier M, Burnand B, Paradis G.

J Am Heart Assoc. 2014 Apr 10;3(2):e000718. doi: 10.1161/JAHA.113.000718. Review.

2.

Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials.

Santschi V, Chiolero A, Paradis G, Colosimo AL, Burnand B.

Diabetes Care. 2012 Dec;35(12):2706-17. doi: 10.2337/dc12-0369. Review.

3.

Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.

Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G.

Arch Intern Med. 2011 Sep 12;171(16):1441-53. doi: 10.1001/archinternmed.2011.399. Review.

PMID:
21911628
4.

Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation.

Mann KK, Padovani AM, Guo Q, Colosimo AL, Lee HY, Kurie JM, Miller WH Jr.

J Clin Invest. 2005 Oct;115(10):2924-33. Epub 2005 Sep 22.

5.

Antimony trioxide-induced apoptosis is dependent on SEK1/JNK signaling.

Mann KK, Davison K, Colombo M, Colosimo AL, Diaz Z, Padovani AM, Guo Q, Scrivens PJ, Gao W, Mader S, Miller WH Jr.

Toxicol Lett. 2006 Jan 5;160(2):158-70. Epub 2005 Aug 19.

PMID:
16112521
6.

A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.

Mann KK, Rephaeli A, Colosimo AL, Diaz Z, Nudelman A, Levovich I, Jing Y, Waxman S, Miller WH Jr.

Mol Cancer Res. 2003 Oct;1(12):903-12.

7.
8.

Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF.

Liu Y, Colosimo AL, Yang XJ, Liao D.

Mol Cell Biol. 2000 Aug;20(15):5540-53.

Supplemental Content

Loading ...
Support Center